Dec. 21 at 7:30 PM
$XPL looks good. Holding, gathering strength. Permit greenlight should be announced by EOY. That aint much time left. When it goes it goes hard. Accumulating.
$ALT gotta remember positive Phase 2b pemvidutide results, recent dip is a gift. Looking for entry.
$GALT Wainwright raised the target, HC 1 promising biomarker data, NAVIGATE trial advancements in liver fibrosis, could be a swing. No position yet.
$GEMG low volatility with improving on-balance volume, could be nothing could also be setting up for potential rebound.